Melanotan Ii vs Testosterone for libido
Short answer: For libido, users rate them about the same: 96% report improvement with Melanotan Ii (47 reports) and 93% with Testosterone (70 reports).
Melanotan Ii has 1 meta-analyses and 1 randomized trials on PubMed; Testosterone has 75 and 125.
Based on 145 reports about Melanotan Ii and 822 about Testosterone. Not medical advice.
| Melanotan Ii Peptide | Testosterone Medication | |
|---|---|---|
| User score | 61 | 54 |
| Verdict | Mostly positive | Mostly positive |
| Positive of reports that state an outcome | 63% | 77% |
| Reports | 145 | 822 |
| Research | BResearch: Moderate | AResearch: Strong |
| Meta-analyses / RCTs | 1 / 1 | 75 / 125 |
| Mainly used for | ||
| Weight loss % reporting improvement | 100% (11) | 93% (45) |
| Appetite % reporting improvement | 67% (6) | — |
| Focus % reporting improvement | — | 82% (28) |
| Energy % reporting improvement | — | 92% (76) |
| Sleep % reporting improvement | 0% (4) | 79% (19) |
| Anxiety % reporting improvement | — | 80% (25) |
| Mood % reporting improvement | 40% (5) | 88% (104) |
| Memory % reporting improvement | — | 100% (2) |
| Performance % reporting improvement | 100% (5) | 97% (149) |
| Recovery % reporting improvement | — | 91% (23) |
| Pain & inflammation % reporting improvement | — | 67% (6) |
| Libido % reporting improvement | 96% (47) | 93% (70) |
| Hormones % reporting improvement | — | 90% (91) |
| Heart & lipids % reporting improvement | 33% (3) | 62% (8) |
| Skin & hair % reporting improvement | 91% (67) | 40% (5) |
| Immunity % reporting improvement | 100% (2) | — |
| Longevity % reporting improvement | — | 50% (2) |
| Common side effects | nausea, flushing, freckles, darkened moles | suppression, hair loss, acne, water retention |
| Typical dose reported | Not listed | 200 mg / weekly |
Almost all studies are in the preclinical phase. There are currently no effective clinical treatments for MC4R-deficient obese patients, although MC4R agonists are being developed and are entering phase I and II trials.
Int J Obes (Lond), 2014 ↗“I've found that getting sun within 3-12 hours will produce the desired result.”
The guidelines also provide recommendations regarding identification of patients, dosing, monitoring, and follow-up. This Practice Pearl will discuss evidence-based testosterone therapy for management of HSDD in postmenopausal women.
Menopause, 2023 ↗“Feel the best I've ever felt in my life. TRT and peptides have been game changers for me!”
Related comparisons
Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate